„We must learn to create magical spheres that ... only hit the pathogens.”
Paul Ehrlich 1854-1915
MEDWAYS NETWORK MEETING IN RUDOLSTADT: On Friday afternoon, AEROPHARM opened its doors to interested medways members. In addition to a site tour of the respiratory drug producer, which belongs to Novartis, there were excellent presentations on current topics in federal politics and EU regulation for clinical research projects, among others.
JOINT INTERVIEW WITH bmIt: What was so special about the start-up? What was the early phase of the company's foundation like? bmIt investment manager Stefan Jahn and managing director Dr. Marc Lehmann jointly answered these and more questions from the Thüringer Aufbaubank.
DEVELOPMENT OF NEW THERAPY OPTIONS
In a first field of application we focus on the targeted transport of active substances in liver cells. We are thus creating a therapeutic option for the treatment of patients with septic cholestasis with the aim of reducing the extremely high mortality rate caused by this complication.